$ADNT

Herberg David sold $16K of ADNT

Herberg David (EVP, EMEA) sold 699 shares of Adient plc (ADNT) at $22.58 on 2026-06-04.

Original reporting
SEC EDGAR · Herberg David
Published Jun 5, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ADNT
Neutral
medium confidence
Mentioned
$ADNT
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ADNTNeutralLow
01

Why it matters

This disclosure may slightly affect short-term sentiment, but there is no accompanying guidance, deal, or operational update.

02

Market read

Traders may monitor for follow-on insider activity, but this single small sale is unlikely to drive a major repricing.

03

What to watch

The absolute size ($15.8k) is small relative to typical institutional flows, reducing the likelihood of a sustained price move.

Relevance 5/10Novelty 6/10Timing: After-hours/next-session read-through from a 2026-06-04 insider sale filed 2026-06-05

Background

SEC Form 4 discloses insider transactions; these are often routine and primarily useful for sentiment/positioning rather than new fundamentals.

Company-level read

Ticker impact

$ADNTNeutralMedium confidence
Context

Adient’s EVP, EMEA (Herberg David) sold 699 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-04.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is a routine insider sale with no 10b5-1 plan stated and no accompanying operational/financial news, so it typically has limited price impact unless unusually large or paired with other disclosures.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide change.

None indicated.

None indicated.

Counterpoint

Without a stated 10b5-1 plan, the sale could reflect diversification or personal liquidity rather than bearish expectations.

Key entities

  • Adient plc

    Subject of the insider transaction disclosure (EVP, EMEA sale).

  • Herberg David

    EVP, EMEA who sold 699 shares at $22.58 on 2026-06-04.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ADNTMedAI 8/10

Adient FY26 slides: cash flow strong despite Q4 earnings miss

Adient (ADNT) reported Q4 adjusted earnings of $0.52 per share, missing estimates of $0.66, while full-year revenue grew 4% to $15.2B. Adjusted EBITDA remained flat at $884M, with margins compressing. Free cash flow was $222M, including $60M in timing-related benefits. The stock rose 1.83% post-earnings. Management guided for EBITDA growth in FY2027 despite expected revenue decline.

$ADNTMed

Adient: Fiscal Q4 Earnings Snapshot

Adient PLC (ADNT) reported a fiscal Q4 loss of $47M, or 62 cents per share, missing estimates of 63 cents per share. Revenue was $3.73B, beating forecasts of $3.59B. The company expects full-year revenue between $14.8B and $15B. Shares are down 12% YTD and 30% over the past year.

$ADNTHighAI 8/10

Adient announces increased share repurchase authorization and adoption of tax benefits preservation plan

Adient (ADNT) increased its share repurchase authorization by $400M, bringing the total to $1B, with $435M remaining. The company also adopted a Tax Benefits Preservation Plan to protect its U.S. tax attributes, valued at $3.5B, which could reduce future cash tax payments. The plan aims to prevent unintended ownership changes that could limit the use of these tax benefits. According to the company, these moves reflect confidence in its business outlook and commitment to shareholder value.